EDTA, disodium salt, dihydrate
Key Features and Details
Ethylenediaminetetraacetic Acid Trisodium Salt Hydrate
SYNONYMS: EDTA Trisodium salt hydrate; Edetic acid; Tricon BW; Celon A; Endrate; (Ethylenedinitrilo)tetraacetic acid trisodium salt hydrate; Edathamil; EDTA trisodium salt hydrate; Edathamil hydrate ;EDTA hydrate; Versene; [Ethylenedinitrilo] tetraacetic acid trisodium salt hydrate
CAS: #
85715-60-2
MOLECULAR FORMULA: C10H13N2O8Na3·×H2O
MOLECULAR WEIGHT: 376.204 g/mol
EC No: 200-449-4
MDL No: MFCD00149675
You need to register an account with us
to be able to place an order, Click to Register.
PRODUCT DESCRIPTION
Ethylenediaminetetraacetic Acid Trisodium Salt Hydrate
Application Notes
Ethylenediaminetetraacetic Acid Trisodium Salt Hydrate is a divalent cation chelator used in some electrophoresis buffer systems. Some proteolytic enzymes and nucleases are divalent cation dependent. The addition of EDTA reduces the chance of sample degredation. Used to eliminate inhibition of enzyme catalysed reactions due to traces of heavy metals. The addition of EDTA may interfere with metal ion-dependent biological processes. A reversible metalloprotease inhibitor.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
SPECIFICATIONS
SKU: 02151088-CF
Base Catalog Number: 151088
Alternate Names: EDTA Trisodium salt hydrate; Edetic acid; Tricon BW; Celon A; Endrate; (Ethylenedinitrilo)tetraacetic acid trisodium salt hydrate; Edathamil; EDTA trisodium salt hydrate; Edathamil hydrate ;EDTA hydrate; Versene; [Ethylenedinitrilo] tetraacetic acid trisodium salt hydrate
CAS
: #
85715-60-2
EC No
: 200-449-4
Format
: Crystalline powder
Hazard Statements
: H315-H319-H335
MDL No
: MFCD00149675
Melting Point
: 245 deg C
Molecular Formula
: C10H13N2O8Na3·×H2O
Molecular Weight
: 376.204 g/mol
PPE
: Dust mask, Eyeshields, Gloves
RTECS No
: AH4025000
Safety Symbol
: GHS07
Solubility
: SOL IN SOLN OF ALKALI HYDROXIDES
Typical Working Concentration
: Effective concentration as reversible metalloprotease inhibitor is typically 1-10 mM.
Vapor Pressure
: 1.50X10-12 mm Hg at 25 deg C /Extrapolated/
